Transepithelial leak in Barrett's esophagus patients: the role of proton pump inhibitors

To determine if the observed paracellular sucrose leak in Barrett's esophagus patients is due to their proton pump inhibitor (PPI) use. The in vivo sucrose permeability test was administered to healthy controls, to Barrett's patients and to non-Barrett's patients on continuous PPI the...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	World journal of gastroenterology : WJG 2012-06, Vol.18 (22), p.2793-2797
Hauptverfasser:	Farrell, Christopher, Morgan, Melissa, Tully, Owen, Wolov, Kevin, Kearney, Keith, Ngo, Benjamin, Mercogliano, Giancarlo, Thornton, James J, Valenzano, Mary Carmen, Mullin, James M
Format:	Artikel
Sprache:	eng
Schlagworte:	Barrett Esophagus - drug therapy Barrett Esophagus - metabolism Barrett Esophagus - pathology Brief Case-Control Studies Epithelial Cells - drug effects Epithelial Cells - metabolism Epithelial Cells - pathology Esophagus - drug effects Esophagus - metabolism Esophagus - pathology Humans Metaplasia Permeability Philadelphia Proton Pump Inhibitors - therapeutic use Sucrose Time Factors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!